Methastar 0.2mg Injection
Marketer
Cadila Pharmaceuticals Ltd
Salt Composition
Methylergometrine (0.2mg)
Overview Methastar 0.2mg Injection
Uterine bleeding following childbirth or termination of pregnancy may be managed with Methastar 0.2mg Injection. This medication enhances uterine smooth muscle contractility, boosting contraction frequency, strength, and overall tone to minimize hemorrhage. Administration is strictly by intravenous or intramuscular injection in a hospital setting; self-administration is prohibited. Dosage and frequency are determined by your physician based on your individual needs and condition, with the goal of symptom improvement. Headache, elevated blood pressure, and convulsions are potential side effects; report any concerning symptoms to your doctor, who may offer strategies for mitigation. Alcohol consumption should be avoided during treatment. Prior to initiating Methastar, disclose any history of hypertension or cardiac disease to your doctor, along with a complete list of all other medications you are currently using, as interactions may compromise efficacy or alter the drug's effects.
Uses of Methastar 0.2mg Injection
Hemorrhage postpartum
Major Benefits of Methastar 0.2mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Methastar 0.2mg Injection:
- High blood pressure
- Headache
- Seizure
How to use Methastar 0.2mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Methastar 0.2mg Injection works:
Methastar 0.2mg Injection, derived from ergot alkaloids, induces prolonged uterine smooth muscle contractions. This vasoconstrictive effect reduces postpartum hemorrhage.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Methastar 0.2mg Injection may pose safety risks; physician consultation is advised.
PregnancyUNSAFE
Administering Methastar 0.2mg Injection to pregnant individuals poses a substantial risk. Pregnant women should consult their physician before use; research in animal models and human studies has revealed considerable adverse effects on fetal development.
Breast feedingCAUTION
Administering Methastar 0.2mg Injection to breastfeeding mothers requires careful consideration. Lactation should be discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingCONSULT YOUR DOCTOR
Methastar 0.2mg Injection's effect on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Data regarding Methastar 0.2mg Injection use in patients exhibiting renal impairment is scarce. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Methastar 0.2mg Injection's use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Methastar 0.2mg Injection :
NA
Facts to Know About Methastar 0.2mg Injection
| Label | Value |
|---|---|
| Chemical Category | Ergoline alkaloids |
| Developing Habits | No. |
| Treatment Category | OBSTETRICS AND GYNECOLOGY |
| Action Class | Drugs inducing uterine contraction and abortion |
3,018 People bought this recently